| Name | Holly Glen Healthcare |
|---|---|
| Location | 4293 Monroe St, Toledo, Ohio |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 98 |
| Occupancy Rate | 39.69% |
| Medicare ID (CCN) | 365849 |
| Legal Business Name | Holly Glen Healthcare Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1073095394 |
| Organization Name | HOLLY GLEN HEALTHCARE LLC |
| Address | 4293 Monroe St, Toledo, OH 43606 |
| Phone Number | 419-474-6021 |
News Archive
As hurricane season gets into full swing, mental health teams will be ready to respond and help survivors cope with possible devastation. Psychologists have analyzed decades of research and found that disaster response strategies should address the needs of the population affected, specifically those with disabilities and mental disorders.
3Care Therapeutics, a manufacturer of nutritional supplements for treating common chronic health problems, announces the release of the 3Care BioSystems Program, a simplified nutritional program that helps practitioners improve patients' health and achieve thriving nutrition practices. The Program is administered via a free, easy-to-use software application; and unlike more complicated therapeutic lifestyle change programs, the 3Care Program encourages improved health outcomes through better patient compliance.
Celgene International Sàrl, a subsidiary of Celgene Corporation, today announced that results from three phase III studies evaluating the use of continuous REVLIMID(lenalidomide) treatment in newly diagnosed multiple myeloma (MM) patients or maintenance treatment with lenalidomide following autologous stem cell transplant were published online in the May 10, 2012 edition of the New England Journal of Medicine.
In response to an FDA notice issued on December 3, 2009, in which the Agency recommended that healthcare facilities discontinue use of the STERIS System 1® (SS1) sterile processing system, hospitals throughout the U.S. are faced with the task of finding acceptable alternatives to that product.
› Verified 2 days ago
| NPI Number | 1295490217 |
| Organization Name | BUCKEYE FOREST AT TOLEDO LLC |
| Address | 4293 Monroe St, Toledo, OH 43606 |
| Phone Number | 419-474-6021 |
News Archive
As hurricane season gets into full swing, mental health teams will be ready to respond and help survivors cope with possible devastation. Psychologists have analyzed decades of research and found that disaster response strategies should address the needs of the population affected, specifically those with disabilities and mental disorders.
3Care Therapeutics, a manufacturer of nutritional supplements for treating common chronic health problems, announces the release of the 3Care BioSystems Program, a simplified nutritional program that helps practitioners improve patients' health and achieve thriving nutrition practices. The Program is administered via a free, easy-to-use software application; and unlike more complicated therapeutic lifestyle change programs, the 3Care Program encourages improved health outcomes through better patient compliance.
Celgene International Sàrl, a subsidiary of Celgene Corporation, today announced that results from three phase III studies evaluating the use of continuous REVLIMID(lenalidomide) treatment in newly diagnosed multiple myeloma (MM) patients or maintenance treatment with lenalidomide following autologous stem cell transplant were published online in the May 10, 2012 edition of the New England Journal of Medicine.
In response to an FDA notice issued on December 3, 2009, in which the Agency recommended that healthcare facilities discontinue use of the STERIS System 1® (SS1) sterile processing system, hospitals throughout the U.S. are faced with the task of finding acceptable alternatives to that product.
› Verified 2 days ago
| NPI Number | 1477595080 |
| Organization Name | HEARTLAND-HOLLY GLEN OF TOLEDO OH LLC |
| Doing Business As | HEARTLAND - HOLLY GLEN |
| Address | 4293 Monroe St, Toledo, OH 43606 |
| Phone Number | 419-474-6021 |
News Archive
As hurricane season gets into full swing, mental health teams will be ready to respond and help survivors cope with possible devastation. Psychologists have analyzed decades of research and found that disaster response strategies should address the needs of the population affected, specifically those with disabilities and mental disorders.
3Care Therapeutics, a manufacturer of nutritional supplements for treating common chronic health problems, announces the release of the 3Care BioSystems Program, a simplified nutritional program that helps practitioners improve patients' health and achieve thriving nutrition practices. The Program is administered via a free, easy-to-use software application; and unlike more complicated therapeutic lifestyle change programs, the 3Care Program encourages improved health outcomes through better patient compliance.
Celgene International Sàrl, a subsidiary of Celgene Corporation, today announced that results from three phase III studies evaluating the use of continuous REVLIMID(lenalidomide) treatment in newly diagnosed multiple myeloma (MM) patients or maintenance treatment with lenalidomide following autologous stem cell transplant were published online in the May 10, 2012 edition of the New England Journal of Medicine.
In response to an FDA notice issued on December 3, 2009, in which the Agency recommended that healthcare facilities discontinue use of the STERIS System 1® (SS1) sterile processing system, hospitals throughout the U.S. are faced with the task of finding acceptable alternatives to that product.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
As hurricane season gets into full swing, mental health teams will be ready to respond and help survivors cope with possible devastation. Psychologists have analyzed decades of research and found that disaster response strategies should address the needs of the population affected, specifically those with disabilities and mental disorders.
3Care Therapeutics, a manufacturer of nutritional supplements for treating common chronic health problems, announces the release of the 3Care BioSystems Program, a simplified nutritional program that helps practitioners improve patients' health and achieve thriving nutrition practices. The Program is administered via a free, easy-to-use software application; and unlike more complicated therapeutic lifestyle change programs, the 3Care Program encourages improved health outcomes through better patient compliance.
Celgene International Sàrl, a subsidiary of Celgene Corporation, today announced that results from three phase III studies evaluating the use of continuous REVLIMID(lenalidomide) treatment in newly diagnosed multiple myeloma (MM) patients or maintenance treatment with lenalidomide following autologous stem cell transplant were published online in the May 10, 2012 edition of the New England Journal of Medicine.
In response to an FDA notice issued on December 3, 2009, in which the Agency recommended that healthcare facilities discontinue use of the STERIS System 1® (SS1) sterile processing system, hospitals throughout the U.S. are faced with the task of finding acceptable alternatives to that product.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $975 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 32.63 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.08 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 22.03 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.13 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 15.73 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.74 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.2 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.41 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 87.34 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 33.95 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.43 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.63 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 91.88 | 95.98 |